Dana Farber Cancer Institute Brookline Avenue — Boston, Massachusetts

Dana Farber Cancer Institute Brookline Avenue is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Brookline Avenue has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Advanced Solid Tumors, Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Brookline Avenue?

Dana Farber Cancer Institute Brookline Avenue has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Brookline Avenue conducted?

Dana Farber Cancer Institute Brookline Avenue has 3 clinical trials on record, with 3 currently active. Their work covers Advanced Solid Tumors, Ovarian Cancer, Fallopian Tube Cancer.

Is Dana Farber Cancer Institute Brookline Avenue accredited by Crixeo Health?

Dana Farber Cancer Institute Brookline Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Brookline Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.